LLM Tool for Physician Workflow

(SHIFT Trial)

EB
HS
Overseen ByHaideliza Soto Calderon
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new tool designed to assist doctors with paperwork. The tool uses advanced technology to draft handoff notes, which are crucial for maintaining patient care during shift changes. The study aims to determine if this tool can reduce the time doctors spend on paperwork and alleviate their exhaustion. Doctors working in general medicine with shifts of at least five consecutive days may be suitable candidates for this trial. As an unphased trial, it offers a unique opportunity to contribute to innovative solutions that could enhance healthcare efficiency.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this LLM tool is safe for physician workflow?

Research has shown that tools like the one studied in this trial are generally safe for use in medical settings. These tools assist in creating drafts for patient handoffs, which are summaries provided when transferring a patient from one doctor to another.

Safety checks from these studies indicate that users receive notes created by these tools positively. No reports have linked harmful effects directly to using these tools. Thus, while the tool saves time by drafting handoff notes, it does not pose a risk to users.

However, doctors must review and edit these drafts before finalization. This step ensures the information is accurate and meets the quality expected in medical documentation.12345

Why are researchers excited about this trial?

Researchers are excited about the LLM tool because it has the potential to streamline physician workflows by using AI to draft handoff documents. Unlike the standard practice, where doctors manually prepare these documents, the LLM tool offers automated draft generation, saving time and reducing the risk of errors. This innovative approach allows physicians to focus more on patient care by minimizing administrative burdens.

What evidence suggests that the LLM tool is effective for reducing documentation burden?

Studies have shown that large language models (LLMs) can help doctors save time when writing patient handoff notes. Automated tools rate these AI-generated drafts highly for quality, and doctors can edit them to meet their standards. In this trial, participants in the intervention arm will use an LLM-assisted draft generation feature, which research indicates is practical and effective in reducing the time doctors spend on paperwork. Surveys also show that more doctors recognize the benefits of using LLMs in their work. Overall, this suggests that LLM tools could make writing handoffs faster and less tiring for doctors.12346

Are You a Good Fit for This Trial?

This trial is for general medicine attending physicians at HUP (Medicine, Solid Oncology) or PPMC (Medicine) services who are scheduled to work for 5 or more consecutive days. It excludes 'jeopardy attendings' and moonlighters.

Inclusion Criteria

General medicine attending physicians at HUP (Medicine, Solid Oncology) or PPMC (Medicine) services
Scheduled for ≥5 consecutive days on service

Exclusion Criteria

Jeopardy attendings and moonlighters

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Intervention

Hospitalists use the AI-assisted draft generation feature within Carelign for handoff preparation

12 weeks
Continuous use during rotations

Control

Hospitalists continue using standard handoff workflows without AI assistance

12 weeks
Continuous use during rotations

Follow-up

Participants are monitored for documentation burden and work exhaustion

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • LLM tool
Trial Overview The trial tests an AI-powered LLM tool designed to draft medical handoffs within Carelign, a communication tool adjacent to electronic health records. Physicians will be randomly assigned to use the AI feature and must review and edit any drafts before finalizing them.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: LLM ToolExperimental Treatment1 Intervention
Group II: Standard of careActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Citations

Developing and Evaluating Large Language Model ...... handoff tools as feasible, efficient, and effective. In ... Automated Evaluation Scores, Large Language Model (LLM)–Generated and Physician- ...
Developing and Evaluating Large Language Model ...... handoff tools as feasible, efficient, and effective. In April ... Automated Evaluation Scores, Large Language Model (LLM)–Generated and Physician- ...
AI-Written Patient Handoff Notes May Save Physicians TimeThough using large language models (LLM) that drive artificial ... When AI tools that measure text similarity evaluated the LLM ...
Shifts in emergency physicians' attitudes toward large ...A survey of clinicians' views of the utility of large Language models. ... Developing and evaluating large Language model–generated emergency ...
Structured Handoff Using Intelligent Framework for ...The AI feature uses a large language model (LLM) ... Electronic Medical RecordTransitions of CarePhysician WorkflowArtificial Intelligence (AI) ...
AI-generated handoff notes: Study assesses safety and ...Researchers develop and evaluate the accuracy, safety, and utility of large language model-generated emergency medicine handoff notes.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security